Freeha Afshin Azher, MD | |
3706 Highway 95 Ste 101, Bullhead City, AZ 86442-8226 | |
(928) 201-9286 | |
(928) 219-4610 |
Full Name | Freeha Afshin Azher |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 11 Years |
Location | 3706 Highway 95 Ste 101, Bullhead City, Arizona |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1447699897 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 16749 (Nevada) | Secondary |
207Q00000X | Family Medicine | 53235 (Arizona) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
River Valley Hospice | Bullhead city, AZ | Hospice |
Western Arizona Regional Medical Center | Bullhead city, AZ | Hospital |
Valley View Medical Center | Fort mohave, AZ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Dadra Medical Pc | 9830405380 | 2 |
Paragon Physical Therapy And Rehab Llc | 4284902339 | 55 |
News Archive
Boston Scientific Corporation today announced the completion of its acquisition of Sadra Medical, Inc. of Los Gatos, California. The transaction follows the definitive merger agreement announced on November 19, 2010.
By studying intestinal flora in newborn children, Professor Fredrik Bäckhed and his team of researchers at Sahlgrenska Academy, University of Gothenburg, Sweden, aim to discover new methods to treat childhood obesity.
Omeros Corporation today announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of Immunoglobulin A (IgA) nephropathy.
About half of terminally ill patients do not have discussions with their physicians regarding end-of-life choices, according to a Harvard Medical School study published in the Archives of Internal Medicine, the Boston Globe reports.
› Verified 9 days ago
Entity Name | Dadra Medical Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1407252844 PECOS PAC ID: 9830405380 Enrollment ID: O20150831000535 |
News Archive
Boston Scientific Corporation today announced the completion of its acquisition of Sadra Medical, Inc. of Los Gatos, California. The transaction follows the definitive merger agreement announced on November 19, 2010.
By studying intestinal flora in newborn children, Professor Fredrik Bäckhed and his team of researchers at Sahlgrenska Academy, University of Gothenburg, Sweden, aim to discover new methods to treat childhood obesity.
Omeros Corporation today announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of Immunoglobulin A (IgA) nephropathy.
About half of terminally ill patients do not have discussions with their physicians regarding end-of-life choices, according to a Harvard Medical School study published in the Archives of Internal Medicine, the Boston Globe reports.
› Verified 9 days ago
Entity Name | West Coast Wound And Skin Care Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437675980 PECOS PAC ID: 7315212834 Enrollment ID: O20200803000710 |
News Archive
Boston Scientific Corporation today announced the completion of its acquisition of Sadra Medical, Inc. of Los Gatos, California. The transaction follows the definitive merger agreement announced on November 19, 2010.
By studying intestinal flora in newborn children, Professor Fredrik Bäckhed and his team of researchers at Sahlgrenska Academy, University of Gothenburg, Sweden, aim to discover new methods to treat childhood obesity.
Omeros Corporation today announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of Immunoglobulin A (IgA) nephropathy.
About half of terminally ill patients do not have discussions with their physicians regarding end-of-life choices, according to a Harvard Medical School study published in the Archives of Internal Medicine, the Boston Globe reports.
› Verified 9 days ago
Entity Name | Dadra Now Care Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457081861 PECOS PAC ID: 2668848052 Enrollment ID: O20221027000346 |
News Archive
Boston Scientific Corporation today announced the completion of its acquisition of Sadra Medical, Inc. of Los Gatos, California. The transaction follows the definitive merger agreement announced on November 19, 2010.
By studying intestinal flora in newborn children, Professor Fredrik Bäckhed and his team of researchers at Sahlgrenska Academy, University of Gothenburg, Sweden, aim to discover new methods to treat childhood obesity.
Omeros Corporation today announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of Immunoglobulin A (IgA) nephropathy.
About half of terminally ill patients do not have discussions with their physicians regarding end-of-life choices, according to a Harvard Medical School study published in the Archives of Internal Medicine, the Boston Globe reports.
› Verified 9 days ago
Entity Name | Dadra Hospital Medicine Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184249799 PECOS PAC ID: 8729455837 Enrollment ID: O20221102002273 |
News Archive
Boston Scientific Corporation today announced the completion of its acquisition of Sadra Medical, Inc. of Los Gatos, California. The transaction follows the definitive merger agreement announced on November 19, 2010.
By studying intestinal flora in newborn children, Professor Fredrik Bäckhed and his team of researchers at Sahlgrenska Academy, University of Gothenburg, Sweden, aim to discover new methods to treat childhood obesity.
Omeros Corporation today announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of Immunoglobulin A (IgA) nephropathy.
About half of terminally ill patients do not have discussions with their physicians regarding end-of-life choices, according to a Harvard Medical School study published in the Archives of Internal Medicine, the Boston Globe reports.
› Verified 9 days ago
Entity Name | Dadra Community Care Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1114657517 PECOS PAC ID: 4981073509 Enrollment ID: O20221202002485 |
News Archive
Boston Scientific Corporation today announced the completion of its acquisition of Sadra Medical, Inc. of Los Gatos, California. The transaction follows the definitive merger agreement announced on November 19, 2010.
By studying intestinal flora in newborn children, Professor Fredrik Bäckhed and his team of researchers at Sahlgrenska Academy, University of Gothenburg, Sweden, aim to discover new methods to treat childhood obesity.
Omeros Corporation today announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of Immunoglobulin A (IgA) nephropathy.
About half of terminally ill patients do not have discussions with their physicians regarding end-of-life choices, according to a Harvard Medical School study published in the Archives of Internal Medicine, the Boston Globe reports.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Freeha Afshin Azher, MD 3706 Highway 95 Ste 101, Bullhead City, AZ 86442-8226 Ph: (928) 201-9286 | Freeha Afshin Azher, MD 3706 Highway 95 Ste 101, Bullhead City, AZ 86442-8226 Ph: (928) 201-9286 |
News Archive
Boston Scientific Corporation today announced the completion of its acquisition of Sadra Medical, Inc. of Los Gatos, California. The transaction follows the definitive merger agreement announced on November 19, 2010.
By studying intestinal flora in newborn children, Professor Fredrik Bäckhed and his team of researchers at Sahlgrenska Academy, University of Gothenburg, Sweden, aim to discover new methods to treat childhood obesity.
Omeros Corporation today announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of Immunoglobulin A (IgA) nephropathy.
About half of terminally ill patients do not have discussions with their physicians regarding end-of-life choices, according to a Harvard Medical School study published in the Archives of Internal Medicine, the Boston Globe reports.
› Verified 9 days ago
Ludane Tonie Simmons, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 Canyon Rd Bldg B, Bullhead City, AZ 86442 Phone: 928-763-9290 Fax: 928-763-7628 | |
Summer Charise Aymar, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3641 Highway 95, Bullhead City, AZ 86442 Phone: 928-704-4334 | |
Donald J Wagner, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1355 Ramar Rd, Ste 11, Bullhead City, AZ 86442 Phone: 928-704-7202 Fax: 928-704-9207 | |
Dr. Kevin Frank Brown, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2812 Silver Creek Rd, Bullhead City, AZ 86442 Phone: 928-763-7404 Fax: 928-763-9795 | |
Nathan Eric Beneze, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 Canyon Rd Ste A1, Bullhead City, AZ 86442 Phone: 928-704-4499 | |
Mr. Scott Edward Ewing, FNP-BC Family Medicine Medicare: Medicare Enrolled Practice Location: 1648 Highway 95, Bullhead City, AZ 86442 Phone: 928-758-4114 Fax: 928-758-4650 |